US FDA Reports Millions In Unpaid GDUFA Program Fees

 
• By Derrick Gingery

The $20m in generic drug user fee receivables was 12% of the estimated total to be collected in 2018.

Franklin Currency_1099429328_1200.jpg
The GDUFA carryover balance still increased in FY 2018 because collections again outpaced obligations. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics